Bali P, Lozano-Pope I, Hernandez J, Estrada M, Corr M, Turner M
iScience. 2024; 27(4):109457.
PMID: 38558931
PMC: 10981133.
DOI: 10.1016/j.isci.2024.109457.
Nyabuto G, Wilson J, Heilman S, Kalb R, Kopacz J, Abnave A
Cancers (Basel). 2021; 13(22).
PMID: 34830789
PMC: 8616281.
DOI: 10.3390/cancers13225632.
Rahvar F, Salimi M, Mozdarani H
Genet Mol Biol. 2020; 43(4):e20190230.
PMID: 33211060
PMC: 7783727.
DOI: 10.1590/1678-4685-GMB-2019-0230.
Zaidi M
J Interferon Cytokine Res. 2018; 39(1):30-38.
PMID: 30388040
PMC: 6350411.
DOI: 10.1089/jir.2018.0087.
He T, Sun R, Li Y, Katusic Z
Cell Transplant. 2018; 27(6):1005-1009.
PMID: 29860902
PMC: 6050915.
DOI: 10.1177/0963689718761658.
Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.
Lopes-Bastos B, Jin L, Ruge F, Owen S, Sanders A, Cogle C
Oncotarget. 2017; 8(49):85024-85039.
PMID: 29156701
PMC: 5689591.
DOI: 10.18632/oncotarget.18781.
Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion.
Zhang J, Zhang Y, Wu W, Wang F, Liu X, Shui G
Cell Death Dis. 2017; 8(10):e3151.
PMID: 29072687
PMC: 5680924.
DOI: 10.1038/cddis.2017.559.
hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance.
Wadi S, Tipton A, Trendel J, Khuder S, Vestal D
J Cancer Ther. 2017; 7(13):994-1007.
PMID: 28090373
PMC: 5226657.
DOI: 10.4236/jct.2016.713097.
Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.
Zatula A, Dikic A, Mulder C, Sharma A, Vagbo C, Sousa M
Oncotarget. 2016; 8(12):19427-19442.
PMID: 28038447
PMC: 5386695.
DOI: 10.18632/oncotarget.14294.
Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel.
Tipton A, Nyabuto G, Trendel J, Mazur T, Wilson J, Wadi S
Biochem Biophys Res Commun. 2016; 478(4):1617-23.
PMID: 27590579
PMC: 5030188.
DOI: 10.1016/j.bbrc.2016.08.169.
Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver.
Zhang Y, Davis C, Ryan J, Janney C, Pena M
Clin Exp Metastasis. 2013; 30(7):903-18.
PMID: 23748471
PMC: 3836876.
DOI: 10.1007/s10585-013-9591-8.
IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor.
Gerber S, Sedlacek A, Cron K, Murphy S, Frelinger J, Lord E
Am J Pathol. 2013; 182(6):2345-54.
PMID: 23583648
PMC: 3668027.
DOI: 10.1016/j.ajpath.2013.02.041.
Non-apoptotic toxicity of Pseudomonas aeruginosa toward murine cells.
Roy S, Bonfield T, Tartakoff A
PLoS One. 2013; 8(1):e54245.
PMID: 23358229
PMC: 3554662.
DOI: 10.1371/journal.pone.0054245.
Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs).
Spekker K, Leineweber M, Degrandi D, Ince V, Brunder S, Schmidt S
Med Microbiol Immunol. 2012; 202(3):197-206.
PMID: 23269418
DOI: 10.1007/s00430-012-0281-y.
Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it.
Virreira Winter S, Niedelman W, Jensen K, Rosowski E, Julien L, Spooner E
PLoS One. 2011; 6(9):e24434.
PMID: 21931713
PMC: 3169597.
DOI: 10.1371/journal.pone.0024434.
The two faces of interferon-γ in cancer.
Zaidi M, Merlino G
Clin Cancer Res. 2011; 17(19):6118-24.
PMID: 21705455
PMC: 3186825.
DOI: 10.1158/1078-0432.CCR-11-0482.
The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.
Balasubramanian S, Fan M, Messmer-Blust A, Yang C, Trendel J, Jeyaratnam J
J Biol Chem. 2011; 286(22):20054-64.
PMID: 21502320
PMC: 3103378.
DOI: 10.1074/jbc.M111.249326.
The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase.
Vestal D, Jeyaratnam J
J Interferon Cytokine Res. 2010; 31(1):89-97.
PMID: 21142871
PMC: 3021356.
DOI: 10.1089/jir.2010.0102.
New developments in the induction and antiviral effectors of type I interferon.
Liu S, Sanchez D, Cheng G
Curr Opin Immunol. 2010; 23(1):57-64.
PMID: 21123041
PMC: 3822007.
DOI: 10.1016/j.coi.2010.11.003.
The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.
Messmer-Blust A, Balasubramanian S, Gorbacheva V, Jeyaratnam J, Vestal D
Mol Biol Cell. 2010; 21(14):2514-28.
PMID: 20505078
PMC: 2903678.
DOI: 10.1091/mbc.e09-04-0344.